NPP
LH icon

New Potomac Partners’s Labcorp LH Stock Holding History

New Potomac Partners’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.47M Sell
11,049
-60
-0.5% -$13.2K 1.27% 34
2024
Q2 		$2.26M Buy
11,109
+182
+2% +$37K 1.24% 36
2024
Q1 		$2.39M Buy
10,927
+150
+1% +$33K 1.33% 33
2023
Q4 		$2.45M Sell
10,777
-6
-0.1% -$1.26K 1.46% 27
2023
Q3 		$2.17M Sell
10,783
-1,722
-14% -$363K 1.49% 28
2023
Q2 		$2.59M Buy
12,505
+46
+0.4% +$8.92K 1.71% 21
2023
Q1 		$2.46M Buy
12,459
+80
+0.6% +$16.5K 1.7% 23
2022
Q4 		$2.5M Buy
12,379
+170
+1% +$33.2K 1.85% 20
2022
Q3 		$2.15M Sell
12,209
-105
-0.9% -$21.5K 1.81% 21
2022
Q2 		$2.48M Buy
12,314
+49
+0.4% +$10.4K 1.99% 17
2022
Q1 		$2.78M Sell
12,265
-104
-0.8% -$24.5K 1.95% 19
2021
Q4 		$3.34M Sell
12,369
-163
-1% -$40.4K 2.16% 17
2021
Q3 		$3.03M Sell
12,532
-215
-2% -$54.2K 2.09% 21
2021
Q2 		$3.02M Sell
12,747
-186
-1% -$42.4K 2.05% 20
2021
Q1 		$2.83M Sell
12,933
-291
-2% -$58.4K 2.08% 21
2020
Q4 		$2.31M Sell
13,224
-332
-2% -$57.3K 1.67% 27
2020
Q3 		$2.19M Buy
13,556
+15
+0.1% +$2.38K 1.75% 24
2020
Q2 		$1.93M Sell
13,541
-63
-0.5% -$8.72K 1.73% 25
2020
Q1 		$1.48M Sell
13,604
-125
-0.9% -$18K 1.61% 30
2019
Q4 		$2M Buy
13,729
+133
+1% +$19.2K 1.86% 22
2019
Q3 		$1.96M Sell
13,596
-372
-3% -$54.3K 1.96% 20
2019
Q2 		$2.08M Sell
13,968
-378
-3% -$52.7K 2.1% 16
2019
Q1 		$1.89M Sell
14,346
-29
-0.2% -$3.57K 1.91% 21
2018
Q4 		$1.56M Sell
14,375
-117
-0.8% -$15.7K 1.68% 28
2018
Q3 		$2.16M Sell
14,492
-46
-0.3% -$7K 2% 16
2018
Q2 		$2.24M Buy
14,538
+163
+1% +$24.6K 2.17% 14
2018
Q1 		$2M Buy
14,375
+1,973
+16% +$290K 1.96% 20
2017
Q4 		$1.7M Buy
+12,402
New +$1.64M 1.62% 33

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New Potomac Partners's LH Position: Q3 2024 in Review

New Potomac Partners reduced its Labcorp (LH) stake by 0.54% in Q3 2024, selling an estimated $13.2K and leaving 11,049 shares worth $2.47M. The position accounts for 1.27% of the portfolio, ranked #34.

New Potomac Partners first reported a position in LH in Q4 2017 and has held it in 28 quarters since. The position peaked at $3.34M in Q4 2021. 920 funds tracked by Wall St. Rank hold LH as of Q3 2024.

  • New Potomac Partners held 11,049 shares of Labcorp worth $2.47M as of Q3 2024.
  • New Potomac Partners sold 60 Labcorp shares in Q3 2024, an estimated $13.2K.
  • Labcorp made up 1.27% of New Potomac Partners's portfolio in Q3 2024, its #34 holding.
  • New Potomac Partners first reported a position in Labcorp in Q4 2017 and has held it in 28 quarters since.
  • New Potomac Partners's Labcorp position peaked at $3.34M in Q4 2021.
  • 920 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on New Potomac Partners's 13F filing for Q3 2024, filed 8 Nov 2024.